We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Digital Aging Twin Quantifies Biological Aging Across Multiple Organ Systems

By LabMedica International staff writers
Posted on 13 May 2026

Chronological age often fails to capture the wide variability in physiological decline among adults, limiting risk stratification and long-term monitoring. More...

Clinical laboratories also lack standardized tools that can generate reproducible measures of aging across multiple organ systems. Because these systems may age at different rates, objective and interpretable assessment has remained difficult. A new study shows that a computational Digital Aging Twin can quantify both individual and organ-specific aging across adulthood.

Researchers at the Chinese Academy of Sciences’ Institute of Zoology and the China National Center for Bioinformation (Chinese Academy of Sciences), together with Xuanwu Hospital of Capital Medical University and seven partner institutions, developed the Digital Aging Twin to estimate biological age and track organ-level aging rates. The framework advances aging assessment from descriptive markers to quantitative, interpretable modeling. It integrates clinical, imaging, functional, and molecular readouts to generate multiscale aging “clocks.”

The system is organized into three tiers. The first is a core capacity clock that combines 240 physiological indicators to reflect overall functional decline. The second is a multimodal clock that uses deep learning to integrate multiple molecular data layers, including DNA methylation, RNA transcripts, proteins, metabolites, and gut microbiome profiles, while weighting the most informative inputs. The third consists of organ-specific clocks for the brain, liver, lungs, muscles, blood vessels, and skin, built from clinical markers, plasma proteins, and imaging features.

Study data were drawn from mCAS (multicentric Chinese Aging Standardized), a standardized multicenter cohort of 2,019 healthy individuals aged 18 to 91 from Beijing, Quzhou, Ningbo, and Nanchang. More than one billion high-quality data points were collected across clinical tests, cognitive and motor assessments, brain and retinal imaging, gait analysis, and several layers of molecular data, including DNA methylation, RNA transcripts, proteins, metabolites, and gut microbiomes. While the current framework is based on cross-sectional data, the program is being refined with longitudinal follow-up.

The multimodal clock predicted chronological age with a mean absolute error of just 3.87 years, outperforming single-omics clocks. Notably, the analyses revealed that organs age asynchronously, with liver aging showing an inflection near age 40 and brain aging accelerating around age 50. Broader nonlinear waves of change were also observed between ages 40–50 and 60–70.

Additional experiments using plasma proteomics, histology, cell culture, and animal models identified liver-derived coagulation factors, particularly F13B, along with F9 and F10, as direct drivers of vascular and systemic aging. In mice, F13B accelerated aging across multiple tissues, while these factors also induced senescence-related changes in human aortic endothelial cells.

For clinical practicality, the team built “proxy clocks” using 100–108 plasma proteins that closely matched the comprehensive clocks. Lifestyle associations were also noted: greater fruit intake, consistent sleep routines, and moderate walking correlated with slower aging, while smoking, insufficient sleep, and high meal frequency correlated with faster aging. 

The findings, published in Cell on May 8, 2026, represent the first proof-of-concept milestone of China’s X-Age Project and provide a standardized, quantifiable, and interpretable system to localize and compare aging rates across organ systems.
 


New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Online QC Software
Acusera 24•7
New
Platelet Function Analyzer
PL-12
POC Immunoassay Analyzer
Procise DX
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

Lung cancer is the leading cause of cancer deaths worldwide, and screening often yields indeterminate results that prompt invasive workups. Computed tomography (CT) detects small nodules but can flag benign... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.